BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36260109)

  • 1. The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy.
    Lütgendorf-Caucig C; Pelak M; Flechl B; Georg P; Fossati P; Stock M; Traub-Weidinger T; Marosi C; Haberler C; Zechmeister-Machhart G; Hermsmeyer L; Hug E; Staudenherz A
    Strahlenther Onkol; 2023 Apr; 199(4):396-403. PubMed ID: 36260109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
    Boursier C; Zaragori T; Bros M; Bordonne M; Melki S; Taillandier L; Blonski M; Roch V; Marie PY; Karcher G; Imbert L; Verger A
    Eur Radiol; 2023 Oct; 33(10):7089-7098. PubMed ID: 37148355
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kowalski ES; Khairnar R; Gryaznov AA; Kesari V; Koroulakis A; Raghavan P; Chen W; Woodworth G; Mishra M
    Radiat Oncol; 2021 Aug; 16(1):151. PubMed ID: 34399805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
    Iglseder S; Iglseder A; Beliveau V; Heugenhauser J; Gizewski ER; Kerschbaumer J; Stockhammer G; Uprimny C; Virgolini I; Dudas J; Nevinny-Stickel M; Nowosielski M; Scherfler C
    J Neurooncol; 2023 Sep; 164(3):711-720. PubMed ID: 37707754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
    Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [
    Unterrainer M; Kunte SC; Unterrainer LM; Holzgreve A; Delker A; Lindner S; Beyer L; Brendel M; Kunz WG; Winkelmann M; Cyran CC; Ricke J; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Belka C; Niyazi M; Tonn JC; Bartenstein P; Albert NL
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3390-3399. PubMed ID: 37358620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of [
    Milosevic A; Styczen H; Grueneisen J; Li Y; Weber M; Fendler WP; Kirchner J; Damman P; Wrede K; Lazaridis L; Glas M; Guberina M; Eckstein A; Blau T; Herrmann K; Umutlu L; Forsting M; Deuschl C; Schaarschmidt B
    J Nucl Med; 2023 Aug; 64(8):1185-1190. PubMed ID: 37385668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.
    Seystahl K; Stoecklein V; Schüller U; Rushing E; Nicolas G; Schäfer N; Ilhan H; Pangalu A; Weller M; Tonn JC; Sommerauer M; Albert NL
    Neuro Oncol; 2016 Nov; 18(11):1538-1547. PubMed ID: 27106404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of
    Stade F; Dittmar JO; Jäkel O; Kratochwil C; Haberkorn U; Debus J; Combs SE
    Radiat Oncol; 2018 Apr; 13(1):58. PubMed ID: 29606149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.
    Acker G; Kluge A; Lukas M; Conti A; Pasemann D; Meinert F; Anh Nguyen PT; Jelgersma C; Loebel F; Budach V; Vajkoczy P; Furth C; Baur ADJ; Senger C
    Neurosurg Focus; 2019 Jun; 46(6):E9. PubMed ID: 31153151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
    Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.
    Gehler B; Paulsen F; Oksüz MO; Hauser TK; Eschmann SM; Bares R; Pfannenberg C; Bamberg M; Bartenstein P; Belka C; Ganswindt U
    Radiat Oncol; 2009 Nov; 4():56. PubMed ID: 19922642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesions.
    Ensign SF; Agarwal M; Klanderman M; Badawy M; Halfdanarson TR; Johnson DR; Sonbol MB; Kendi AT
    Nucl Med Commun; 2023 Jul; 44(7):663-670. PubMed ID: 37158225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
    Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
    Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor-positive breast lesions on
    Has Simsek D; Isik EG; Engin MN; Kuyumcu S; Mudun A; Sanli Y
    Ann Nucl Med; 2021 Feb; 35(2):270-277. PubMed ID: 33400149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Brain Incidental Lesions Detected by
    Albano D; Treglia G; Dondi F; Bertagna F
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888635
    [No Abstract]   [Full Text] [Related]  

  • 17. PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE.
    Unterrainer M; Lindner S; Beyer L; Gildehaus FJ; Todica A; Mittlmeier LM; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Tonn JC; Albert NL; Bartenstein P; Ilhan H
    Clin Nucl Med; 2021 Aug; 46(8):667-668. PubMed ID: 33782306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.
    Lapa C; Reiter T; Kircher M; Schirbel A; Werner RA; Pelzer T; Pizarro C; Skowasch D; Thomas L; Schlesinger-Irsch U; Thomas D; Bundschuh RA; Bauer WR; Gärtner FC
    Oncotarget; 2016 Nov; 7(47):77807-77814. PubMed ID: 27780922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simpson Grade Revisited - Intraoperative Estimation of the Extent of Resection in Meningiomas Versus Postoperative Somatostatin Receptor Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Ueberschaer M; Vettermann FJ; Forbrig R; Unterrainer M; Siller S; Biczok AM; Thorsteinsdottir J; Cyran CC; Bartenstein P; Tonn JC; Albert NL; Schichor C
    Neurosurgery; 2020 Dec; 88(1):140-146. PubMed ID: 32827256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous
    Maclean J; Fersht N; Sullivan K; Kayani I; Bomanji J; Dickson J; O'Meara C; Short S
    Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):448-458. PubMed ID: 28433399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.